Biopol Chemicals is entering the public markets through SME IPO with an issue size of ₹31.26 crore. The issue consists of a fresh issue of equity shares. The shares are proposed to be listed on NSE & SME.
The IPO subscription window opens on February 6, 2026 and will remain open until February 10, 2026. The company plans to list its shares on February 13, 2026. Being an SME IPO, the issue may appeal to investors familiar with lower liquidity listings.
Biopol Chemicals Limited IPO Timeline
IPO Quick Facts
This section covers the main IPO details of Biopol Chemicals that investors generally review before applying.
IPO Details at a Glance
| Company Name | Biopol Chemicals |
|---|---|
| IPO Segment | SME |
| Sale Type | Fresh Issue |
| Issue Type | Bookbuilding IPO |
| Price | ₹102 – ₹108 Per Share |
| Lot Size | 1,200 Shares |
| Face Value | ₹10 Per Share |
| Exchange | NSE & SME |
Investor Category & Share Allocation
| Investor Category | Shares Offered | % of Issue |
|---|---|---|
| Market Maker | 151,200 | 5.22% |
| Qualified Institutional Buyers (QIB) | 686,400 | 23.71% |
| NII (HNI) | 1,094,400 | 37.81% |
| — bNII > ₹10L | 729,600 | 25.21% |
| — sNII < ₹10L | 364,800 | 12.60% |
| Retail | 962,400 | 33.25% |
| Total Shares Offered | 2,894,400 | 100.00% |
Biopol Chemicals IPO Important Dates
The following table highlights the key dates for the Biopol Chemicals IPO, covering the subscription period and the expected listing timeline.
| IPO Opening Date | 06 Feb 2026 |
|---|---|
| IPO Closing Date | 10 Feb 2026 |
| Allotment Finalization | 11 Feb 2026 |
| Initiation of Refunds | 12 Feb 2026 |
| Credit of Shares | 12 Feb 2026 |
| IPO Listing Date | 13 Feb 2026 |
Biopol Chemicals IPO Size & Structure
| Total IPO Size | ₹31.26 Crore |
|---|---|
| Fresh Issue | ₹31.26 Crore |
Biopol Chemicals IPO Lot Size & Minimum Investment
The table below shows the lot size and investment amount for the Biopol Chemicals IPO, calculated using the cut-off price. The price band for this IPO ranges from ₹102 to ₹108 per share.
Investors can apply for the IPO with a minimum of 1200 shares. Applications must be made in multiples of 1200 shares.
- Retail investors can apply from 2 lot to 2 lots.
- Small HNI (SHNI) investors must apply for at least 3 lots.
- Big HNI (BHNI) investors need to apply for a minimum of 8 lots.
This information helps investors understand the minimum investment required before applying for the IPO.
Note: Retail investors generally apply at the cut-off price, which is ₹108 per share.
| Category | Lots | Shares | Price | Amount |
|---|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹108 | ₹259,200 |
| Retail (Max) | 2 | 2,400 | ₹108 | ₹259,200 |
| S-HNI (Min) | 3 | 3,600 | ₹108 | ₹388,800 |
| S-HNI (Max) | 7 | 8,400 | ₹108 | ₹907,200 |
| B-HNI | 8 | 9,600 | ₹108 | ₹1,036,800 |
Biopol Chemicals IPO GMP (Grey Market Premium)
The latest Biopol Chemicals IPO GMP (Grey Market Premium), along with Kostak rates and Subject to Sauda rates, helps in understanding market sentiment. The current Biopol Chemicals IPO GMP is ₹4 (3.70%), compared to the IPO issue price of ₹108. Based on the current GMP, the expected listing price is around ₹112. The Lowest GMP was ₹0 on 10 Feb 2026, while the highest GMP reached ₹4 on 13 Feb 2026.
Biopol Chemicals IPO was listed on the stock exchange on 13 Feb 2026. The IPO was subscribed 21.02 times. The first reported GMP was ₹0 (0%), while the latest recorded GMP stood at ₹4 (3.7%).Listing Details:
- Issue Price: ₹108 per share.
- Listing Price: ₹111.00 (approx. 2.78% gain)
- Listing Date: 13 Feb 2026
Biopol Chemicals IPO GMP Today - Trend Analysis
| Date | Issue Price (₹) | GMP Price (₹) | Estimated Gain (%) | Estimated Price (₹) | Estimated Profit (₹) |
|---|---|---|---|---|---|
| 13 Feb 2026 | ₹108 | ₹4 | 3.7% | ₹112 | ₹9,600 |
| 12 Feb 2026 | ₹108 | ₹4 | 3.7% | ₹112 | ₹9,600 |
| 11 Feb 2026 | ₹108 | ▲ ₹4 | ▲ 3.7% | ₹112 | ₹9,600 |
| 10 Feb 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 09 Feb 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 07 Feb 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 06 Feb 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 05 Feb 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 04 Feb 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 03 Feb 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 02 Feb 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 01 Feb 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 31 Jan 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 30 Jan 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 29 Jan 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 28 Jan 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 27 Jan 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 26 Jan 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
| 24 Jan 2026 | ₹108 | ₹0 | 0% | ₹108 | ₹0 |
Biopol Chemicals IPO GMP gives retail and institutional investors an idea about short-term market expectations. Although grey market premium does not guarantee listing performance, it is still commonly referred to while analysing IPOs. Investors are advised to look at Biopol Chemicals fundamentals along with IPO GMP data before making any investment decision.
GMP Disclaimer: GMP (Grey Market Premium) prices are unofficial and only reflect market sentiment. We neither participate in grey-market trading nor encourage it. Investors are strongly advised to review the company’s fundamentals, risks, and official documents before considering an investment in the Biopol Chemicals IPO.
Biopol Chemicals IPO Subscription Status
Biopol Chemicals IPO was subscribed 21.02 times overall on the final day of bidding (as of 10 Feb 2026).The subscription opened on 06 Feb 2026. The Retail portion was subscribed 20.27 times, while QIB and NII categories were subscribed 21.05 times and 21.58 times respectively.
Subscription by Category (QIB, NII, Retail, Employee)
Daily Subscription Trend (Day-wise):
| Date | QIB | NII | Retail | Employee | Total |
|---|---|---|---|---|---|
| 06 Feb 2026 | — | 0.14x | 0.19x | — | 0.12x |
| 09 Feb 2026 | 4x | 0.82x | 1.05x | — | 1.65x |
| 10 Feb 2026 | 21.05x | 21.58x | 20.27x | — | 21.02x |
The Biopol Chemicals IPO opened with strong demand on Day-1, supported by active participation from Retail and NII investors.
On Day-2, subscription levels for the Biopol Chemicals IPO rose sharply due to heavy bidding from QIB, followed by Retail investors.
By the end of the bidding period, the IPO was subscribed 21.02x overall, reflecting strong demand from key investor categories, led by NII, followed by Retail and QIB investors. Overall subscription for the Biopol Chemicals IPO increased from 0.12x on Day-1 to 21.02x by the final day.
Biopol Chemicals IPO Final Subscription
| Category | Subscription |
|---|---|
| Qualified Institutional Buyers (QIB) | 21.05x |
| Non-Institutional Investors (NII) | 21.63x |
| Retail Investors | 20.66x |
| Total | 21.17x |
Biopol Chemicals IPO Allotment Status
The Biopol Chemicals IPO allotment status was released on 11 Feb 2026. Investors who applied for the IPO can now check their Biopol Chemicals allotment status online through the official registrar website and NSE / BSE portal.
- 🗓 Allotment Date: 11 Feb 2026
- 📈 Listing Date: 13 Feb 2026
How to Check Biopol Chemicals IPO Allotment Status Online?
Investors can check the Biopol Chemicals IPO allotment status online through BigShare Services Private Limited and NSE websites. All platforms provide easy access to the IPO allotment details.
Just follow the below mentioned steps to check your allotment status.You can also visit
BigShare Services
to know more about the IPO registrar.
Check on BigShare Services Private Limited (IPO Registrar)
- Visit → BigShare Services Private Limited
- Select Biopol Chemicals
- Select Application No / CAF No / Beneficiary ID / PAN Number
- Enter the relevant details and CAPTCHA to proceed further
- Click Search to view allotment status
Check on NSE (National Stock Exchange) Website
- Go to → NSE Website
- Select Equity & SME IPO Bid Details.
- Choose Biopol Chemicals IPO.
- Enter your PAN & Application Number.
- Click on Submit button.
The National Stock Exchange (NSE) provides an online facility to check the Biopol Chemicals IPO allotment status.
Note: Allotment status is published only on the official registrar websites. We do not collect investor data or provide allotment verification directly.
How to Apply for Biopol Chemicals IPO?
Login to Your Trading App
Open your trading app such as Angel One, Zerodha, Upstox, Groww or any brokerage app.
Go to the IPO Section
Navigate to the IPO section in the app, search for the IPO, and enter your bid details.
Enter Your UPI ID
Provide your UPI ID that is linked to your bank account for payment authentication.
Approve the Mandate
Open your UPI app and approve the payment mandate to block the required amount.
Application Confirmation
Application submitted successfully, the funds will remain blocked until allotment is finalized.
Biopol Chemicals IPO Listing Analysis
Below is a quick summary of the Biopol Chemicals IPO issue price, listing price, and listing gain on NSE.
| IPO Status | Issue Price | Listing Price | Listing Gain |
|---|---|---|---|
| Listed (NSE) | ₹108 | ₹111 | ▲ 2.78% |
Biopol Chemicals debuted at ₹111, listing at a premium of +₹3 (+2.78%). The stock declined to ₹105.5, slipping -4.95% and ending -₹3 below (-2.31%). The investment fell to ₹126,600. Investors booked a loss of -₹3,000 per lot.
📌 IPO Issue Price and Lot Size
The IPO of Biopol Chemicals was offered in the price band of ₹102 to ₹108 per share.
- The final issue price was fixed at ₹108.
- One lot consisted of 1200 shares.
- Minimum investment: ₹108 × 1200 = ₹129,600
- Investment after Day-1: ₹105.5 × 1200 = ₹126,600
- By the end of the listing session, investors faced a loss of -₹3,000 per lot.
📌 IPO Subscription Analysis
With a strong overall subscription of 21.02× and QIB participation of 21.05×, the IPO delivered a positive market debut. The stock listed at 2.78% and closed at -2.31%, reflecting sustained buying interest.
| Day | QIB | NNI | Retail | Total |
|---|---|---|---|---|
| Day 1 | 0x | 0.14x | 0.19x | 0.12x |
| Day 2 | 4x | 0.82x | 1.05x | 1.65x |
| Day 3 | 21.05x | 21.58x | 20.27x | 21.02x |
📌 Final Assessment
Overall Outcome: Average IPO
- Subscription Phase: High investor participation
- Listing Phase: Neutral listing performance
- Investor Experience: Limited downside impact
About Biopol Chemicals Limited
Biopol Chemicals Limited was incorporated in 2023 and based in India, is a manufacturer and distributor of specialty chemicals, including silicones, emulsifiers, biochemicals, and polyelectrolytes. With 66-product portfolio and an annual production capacity of 1,825,000 litres, the company serves B2B clients in textiles, agriculture, and home care. Their products are ZDHC Level 3.0 certified, emphasizing sustainability and performance.Â
IPO Financial Summary
- Total Assets changed by 79.27% in FY 2024-2025.
- Total Revenue changed by 181.99% in FY 2024-2025.
- Profit After Tax changed by 46.28% in FY 2024-2025.
- Reserves & Surplus changed by 335.66% in FY 2024-2025.
- Total Borrowings changed by 114.8% in FY 2024-2025.
| Metric | 2025-12-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Total Assets (₹ Cr) | 48.88 | 31.48 | 17.56 |
| Total Revenue (₹ Cr) | 48.97 | 49.15 | 17.43 |
| Profit After Tax (₹ Cr) | 6.00 | 4.33 | 2.96 |
| Reserves & Surplus (₹ Cr) | 11.63 | 5.62 | 1.29 |
| Total Borrowings (₹ Cr) | 14.92 | 7.69 | 3.58 |
Utilisation of Proceeds
The Company proposes to utilise the net IPO proceeds of approximately ₹23.36 crore towards the following objectives:
| # | Purpose | Amount (₹ Cr) | % of Total |
|---|---|---|---|
| 1 | Acquisition of industrial land | 12.26 | 52.48% |
| 2 | Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies | 11.10 | 47.52% |
| Total | 23.36 | 100% | |
Biopol Chemicals IPO Promoter Holding
| Promoter(s) | Mr. Santanu Sarkar and Mr. Vedant Sarkar |
|---|---|
| Pre-Issue Holding | 89.88% |
| Post-Issue Holding | 65.81% |
Biopol Chemicals IPO FAQs
The Biopol Chemicals IPO is a SME Bookbuilding IPO with a total issue size of ₹31.26 crore. The issue consists of a fresh issue of ₹31.26 crore.
The IPO will open for subscription on Fri, 06 Feb 2026 and will close on Tue, 10 Feb 2026.
The shares are being offered at a price band of ₹102 to ₹108 per equity share.
Investors can apply for the IPO with a minimum lot size of 1,200 shares.
At the upper price band, the minimum investment required for one lot is approximately ₹259,200.
The shares of Biopol Chemicals are expected to be listed on NSE & SME on Fri, 13 Feb 2026.
The Grey Market Premium (GMP) of Biopol Chemicals IPO is ₹4.
The expected listing price of Biopol Chemicals IPO is around ₹112 based on current GMP. This indicates a potential return of approximately 3.70% , with an estimated profit of ₹4,800 per lot, subject to market conditions.
The Biopol Chemicals IPO was subscribed 21.17 times on the final day of subscription.
The retail portion is subscribed 20.27 times as of 10 Feb 2026.
The QIB portion is subscribed 21.05 times and the NII portion is subscribed 21.58 times .
The IPO registrar of Biopol Chemicals is BigShare Services Private Limited. BigShare is responsible for processing IPO applications, finalizing allotment, crediting shares, and initiating refunds.
The allotment date is expected on Wed, 11 Feb 2026.
Allotment status is generally updated in the evening (6 PM – 10 PM) on Wed, 11 Feb 2026 on the registrar or exchange website.
Shares are expected to be credited by Thu, 12 Feb 2026.
Refunds for unsuccessful applicants will be initiated on Thu, 12 Feb 2026.
Investors can check refund status via:
- UPI mandate / bank account (NACH, NEFT, RTGS)
- ASBA bank portal
Biopol Chemicals IPO is listed on NSE.
The current share price of Biopol Chemicals Limited is ₹94.25. The stock opened at ₹95.00, hit a high of ₹95.00 and a low of ₹94.25.
Biopol Chemicals Limited share price has decreased by ₹4.95 (4.99%) compared to the previous close. declined 15.09% from its listing price of ₹111.00 on NSE.
Disclaimer: The content published on this website is for informational and educational purposes only and must not be treated as financial, trading or investment advice. Share Market related articles, IPO details, GMP values, subscription data, listing estimates, allotment status and related information reflect market sentiment and public data and may be inaccurate or outdated. Nothing on this website constitutes an offer or recommendation to buy or sell any securities. We are not SEBI registered financial advisors. Investors must consult a qualified SEBI registered financial advisor before making any investment decisions. Any investment made based on the information provided here is entirely at the reader’s own risk. The author and the team at TheFinancialTalks.com shall not be responsible or liable for any financial loss. Investors must conduct thorough due diligence and seek professional financial advice before making any investment decisions.